Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Gangemi

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Giornale Italiano Di Oncologia|April 1, 1989
[Pretreatment evaluation of CA 72.4 in patients with carcinoma of the stomach (0-IV stage) versus CEA, TPA, CA 19-9, FER]F Buda, P Aragona, G Giani, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1997
Negative/low expression of the Met/hepatocyte growth factor receptor identifies papillary thyroid carcinomas with high risk of distant metastasesA Belfiore, P Gangemi, A Costantino, et al.
Endocrine-Related Cancer|March 4, 2008
BRAF(V600E) mutation and the biology of papillary thyroid cancerF Frasca, C Nucera, G Pellegriti, et al.
Pathologica|September 13, 2003
[Benchmarking in pathological anatomy]Palma P Dalla, K Chisté, M G Guarrera, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Giornale Italiano Di Oncologia|April 1, 1989
[Pretreatment evaluation of CA 72.4 in patients with carcinoma of the stomach (0-IV stage) versus CEA, TPA, CA 19-9, FER]F Buda, P Aragona, G Giani, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1997
Negative/low expression of the Met/hepatocyte growth factor receptor identifies papillary thyroid carcinomas with high risk of distant metastasesA Belfiore, P Gangemi, A Costantino, et al.
Endocrine-Related Cancer|March 4, 2008
BRAF(V600E) mutation and the biology of papillary thyroid cancerF Frasca, C Nucera, G Pellegriti, et al.
Pathologica|September 13, 2003
[Benchmarking in pathological anatomy]Palma P Dalla, K Chisté, M G Guarrera, et al.
Pageof 3